22 April 2026 in JMIR Pediatrics and Parenting
Background: The California Advancing and Innovating Medi-Cal (CalAIM) initiative supports Enhanced Care Management (ECM) for high-need pediatric populations but published evidence of the impact of ECM in pediatric populations is lacking. Objective: We evaluated a novel multidisciplinary care model (Pair Team) for delivering ECM services, focusing on implementation and early outcomes for children and adolescents enrolled in California’s Medicaid program (Medi-Cal). Methods: We conducted a retrospective, observational cohort study of Medi-Cal-enrolled children and adolescents who enrolled in Pair Team’s program between July 2022 and November 2024. Program engagement, health care engagement, and depressive symptoms were assessed using program data, electronic health records, and prescription data. Results: The main cohort included 1294 enrollees with 12 months of follow-up data (mean age 8.9 years, 50.3% (651/1294) female, 81.8% (1058/1294) experiencing homelessness). Members averaged 2.8 interactions per month with care team members over the first 3 months and 57.1% (851/1491) were still enrolled at 12 months. In the year prior to enrollment compared to the year postenrollment, the prevalence of an asthma diagnosis increased from 7.8% to 10.0% ( P= .005), outpatient visits increased 7% (rate ratio, RR=1.07, P <.001), emergency department visits decreased 9% (RR=0.91, P= .002), and antibiotic prescriptions increased 41% (RR=1.41, P= .001). For those with depressive symptoms at enrollment, mean PHQ-9 score decreased from 15.4 (SD 4.7) to 10.2 (SD 6.8) after 3 months ( P <.001). Conclusions: An innovative ECM program successfully engaged with and retained high-need pediatric Medicaid patients. Program members had higher engagement with other health care in the year following enrollment, and depressive symptoms improved. These results highlight the potential for this model to improve outcomes for the highest-need pediatric Medicaid patients.
4 February 2026 in Health Affairs Scholar
The United States faces a worsening maternal health crisis, with mortality rates far exceeding those of peer nations and persistent inequities for Black, Indigenous, and rural women. Medicaid finances over 40% of U.S. births, yet fiscal pressure, heightened scrutiny of program spending, and political resistance to benefit expansion constrain states’ ability to adopt new maternal health interventions. In this environment, outcome-indexed public-private partnerships (PPPs) offer a pragmatic pathway to advance maternal health equity while tying expenditures to measurable value. This paper examines the promise and limitations of emerging FemTech innovations such as virtual doula care, remote patient monitoring, and AI-enabled risk-assessment—and the structural barriers that impede their adoption in Medicaid. We argue that innovation failures reflect misaligned incentives rather than lack of technological potential. To address this gap, we propose a coordinated policy framework that aligns the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Medicare & Medicaid Services (CMS) Transforming Maternal Health Model and Medicaid Section 1115 waivers across the innovation lifecycle. This approach enables disciplined experimentation, independent evaluation, and scalable deployment of equity-focused technologies within Medicaid, safeguarding maternal health gains under constrained fiscal conditions.